New weight loss drug HDM1005 shows promise in early safety trial
NCT ID NCT06640647
First seen Dec 16, 2025 · Last updated May 21, 2026 · Updated 20 times
Summary
This early-stage study tested a new drug called HDM1005 in 65 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo as a single shot. The study also looked at changes in weight and other health markers. The goal is to find a new treatment for obesity and overweight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Second Affiliated Hospital of Anhui Medical University
Hefei, China
Conditions
Explore the condition pages connected to this study.